First-line efgartigimod could soon be more than a hypothetical therapeutic option for patients with acetylcholine receptor antibody-positive
Elekta has released a new report outlining radiotherapy’s utility in cancer care titled “2025 Impact Report, Precision Targeting, Global Impact: Cancer Radiotherapy in the 21st Century.”
The report calls for broader adoption, proper…








